SBHMY
Price:
$11.27
Market Cap:
$70.72B
Sino Biopharmaceutical Limited operates as a prominent research and development-centric pharmaceutical conglomerate in the People's Republic of China, functioning as an investment holding company. Its operations are organized into three primary divisions: Modernized Chinese and Chemical Medicines, Investment activities, and other varied business ventures. The firm maintains an extensive product range covering numerous therapeutic categories. Among its offerings are oncology treatments, such as Qingkeshu tablets and Leweixin injections; cardiovascular and cerebrovascular medications, including Kaina and Anrixin tablets; hepatitis remedies like Tianqingganmei injections; and orthopedic solutio...[Read more]
Industry
Biotechnology
IPO Date
2017-09-05
Stock Exchange
OTC
Ticker
SBHMY
Dividends are a key part of long-term returns for investors, and Sino Biopharmaceutical Limited (SBHMY) has a track record worth reviewing. Looking at dividend history for SBHMY gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-06-25
Dividend Yield
1.96%
Annual Dividend
$0.13
P/E Ratio
29.66
Payout Ratio
0
Dividend per Share
$0.08
EPS
0.38
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-06-25 | $0.12761 | $0.12761 | 2026-08-04 | 2026-06-10 |
| 2025-08-29 | $0.1286 | $0.1286 | 2025-10-08 | 2025-08-19 |
| 2025-06-17 | $0.10191 | $0.10191 | 2025-07-25 | 2025-05-29 |
| 2024-09-11 | $0.077243 | $0.077243 | 2024-10-18 | 2024-08-28 |
| 2024-06-12 | $0.076812 | $0.076812 | 2024-07-22 | 2024-05-29 |
| 2023-10-04 | $0.051137 | $0.051137 | 2023-11-13 | 2023-09-14 |
| 2023-06-20 | $0.1536 | $0.1536 | 2023-07-31 | 2023-06-07 |
| 2022-09-06 | $0.15287 | $0.15287 | 2022-10-13 | |
| 2022-06-15 | $0.10191 | $0.10191 | 2022-07-27 | |
| 2021-09-10 | $0.051366 | $0.051366 | 2021-10-19 | |
| 2021-06-17 | $0.103 | $0.103 | 2021-07-27 |
The table below shows Sino Biopharmaceutical Limited (SBHMY) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Sino Biopharmaceutical Limited (SBHMY) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Straumann Holding AG (SAUHF) | 0.01% |
| Straumann Holding AG (SAUHY) | 0.01% |
| Orion Oyj (ORINY) | 0.03% |
| Astellas Pharma Inc. (ALPMF) | 0.04% |
| Astellas Pharma Inc. (ALPMY) | 0.04% |
| bioMérieux S.A. (BMXXY) | 0.01% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Sino Biopharmaceutical Limited (SBHMY) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is SBHMY’s dividend yield?
What is the difference between regular and special dividends?
Has SBHMY increased its dividends over time?
Why might dividend history data be delayed?
How often does SBHMY pay dividends?
What factors impact SBHMY's dividend payments?
Can dividends change over time?
What is SBHMY’s next dividend date?